IGF Inhibition With Xentuzumab Prior to Radical Prostatectomy

NCT05110495 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Xentuzumab

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]